|4Dec 20, 7:10 PM ET

Hendricks Diane 4

4 · Monopar Therapeutics · Filed Dec 20, 2019

Insider Transaction Report

Form 4
Period: 2019-12-18
Transactions
  • Purchase

    Common stock

    2019-12-18$8.00/sh+468,750$3,750,000468,750 total(indirect: See Footnote 1)
Holdings
  • Common stock

    (indirect: See Footnote 2)
    3,055,394.12
Footnotes (2)
  • [F1]This is based upon the 468,750 shares of Monopar Common Stock that DMH Business LLC directly owns. As a manager of DMH Business LLC, Ms. Hendricks may be deemed to share voting and dispositive power over these 468,750 shares. Ms. Hendricks disclaims beneficial ownership of the 468,750 shares held by DMH Business LLC, except to the extent of her pecuniary interest therein.
  • [F2]Gem Pharmaceuticals LLC ("Gem"), an Alabama limited liability company, has voting and investment power over 3,055,394.12 of the shares of common stock held by TacticGem LLC. Diane Hendricks is a manager of Gem and along with other managers collectively have voting control over the securities described herein. Pharma Investments LLC ("Pharma") owns a controlling share of Gem and Diane Hendricks owns a controlling share of Pharma, so Pharma and its controlling shareholders have indirect control over the securities described herein. The managers of Gem and the controlling shareholders of Pharma each disclaim ownership of the shares of common stock owned by Gem, except to the extent of their pecuniary interest therein.

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT